Cargando…
Adamalysins in COVID-19 – Potential mechanisms behind exacerbating the disease
The coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, is a current pandemic that has resulted in nearly 250 million cases and over 5 million deaths. While vaccines have been developed to prevent infection, and most COVID-19 cases end up being fairly light, there are severe cases o...
Autores principales: | de Seabra Rodrigues Dias, Ivo Ricardo, Cao, Zhijian, Kwok, Hang Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010236/ https://www.ncbi.nlm.nih.gov/pubmed/35658218 http://dx.doi.org/10.1016/j.biopha.2022.112970 |
Ejemplares similares
-
Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results
por: Walkiewicz, Katarzyna, et al.
Publicado: (2019) -
CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII
por: Waack, Ursula, et al.
Publicado: (2018) -
Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the D domain of ADAMalysin family proteins
por: Guan, Hong-Hsiang, et al.
Publicado: (2010) -
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19
por: Sun, Fang, et al.
Publicado: (2021) -
Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients
por: Canzano, Paola, et al.
Publicado: (2021)